From: Diabetes mellitus and cardiac complications in thalassemia major patients
Adjusted for no-MIO | Adjusted for no-MIO and covariates | |||
---|---|---|---|---|
OR (95% CI) | P-value | OR (95% CI) | P-value | |
Cardiac complications | 4.23 (2.65-6.76) | <0.0001 | 2.84 (1.71-4.69) # | <0.0001 |
Heart failure | 3.14 (1.87-5.26) | <0.0001 | 2.33 (1.33-4.06) # | 0.003 |
Heart failure at time of study | 3.45 (2.02-5.89) | <0.0001 | 2.48 (1.39-4.43) # | 0.002 |
Hyperkinetic arrhythmias | 4.09 (2.16-7.74) | <0.0001 | 2.21 (1.12-4.37) # | 0.023 |
Myocardial fibrosis | 2.12 (1.24-3.63) | 0.006 | 1.91 (1.11-3.29) § | 0.021 |
Heart dysfunction (LV and/or RV) | 1.45 (0.37-2.33) | 0.093 | ||
Biventricular dysfunction | 1.46 (0.78-2.72) | 0.235 | ||
LV dysfunction | 0.77 (0.37-1.60) | 0.487 | 1.62 (0.44-5.97) * | 0.470 |
RV dysfunction | 1.82 (1.01-3.30) | 0.048 | 1.33 (0.71-2.49) * | 0.366 |